Home
Conditions
Gastrointestinal Stromal Tumors

Clinical trial condition

Gastrointestinal Stromal Tumors

Explore clinical trials studying Gastrointestinal Stromal Tumors. Study availability and eligibility vary by location and protocol.

244 public trials 45 recruiting studies

Refine in advanced search Browse all conditions

Gastrointestinal Stromal Tumors trial results

Completed

Safety And Efficacy Study Of Sunitinib Malate In Chinese Patients With Imatinib Resistant Or Intolerant Malignant Gastrointestinal Stromal Tumor

NCT00793871

Conditions: Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +8 more
Locations: Nanjing Bayi Hospital Nanjing, Jiangsu, China

Cancer Institute & Hospital Chinese Academy of Medical Sciences and PUMC Beijing, China

Beijing Cancer Hospital Beijing, China

307 Hospital of PLA Beijing, China

View Trial Details

Completed

B-Receptor Signaling in Cardiomyopathy

NCT01135849

Conditions: Adenocarcinoma, Adenoma, Amyloidosis, +140 more
Locations: Stanford University School of Medicine Stanford, California, United States

View Trial Details

Completed

Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer

NCT00397384

Conditions: Adenocarcinoma, Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, +135 more
Locations: Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Completed

Open-label Trial of GlivecWith Unresectable or Metastatic Malignant Gastrointestinal Stromal Tumors

NCT00293124

Conditions: Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +6 more
Locations: AKH, Universitätsklinik für Innere Medizin 1 Vienna, Austria

Institute of Oncology Sarajevo Sarajevo, Bosnia and Herzegovina

SBALO National Oncology Center Sofia, Bulgaria

National Oncological Center Hospital Sofia, Bulgaria

View all 16 locations

View Trial Details

Completed

Imatinib Mesylate in Treating Patients With Relapsed or Refractory Solid Tumors of Childhood

NCT00030667

Conditions: Childhood Desmoplastic Small Round Cell Tumor, Childhood Synovial Sarcoma, Desmoplastic Small Round Cell Tumor, +26 more
Locations: Children's Oncology Group Arcadia, California, United States

View Trial Details

Completed

WB-DWI for Early Prediction of Therapy Response in Patients With Advanced Metastatic GIST Treated With Regorafenib

NCT01265979

Conditions: Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +10 more
Locations: Radiology Department Leuven, Belgium

View Trial Details

Completed

Perioperative Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor

NCT01267695

Conditions: Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +7 more
Locations: Peking University School of Oncology Beijing, China

View Trial Details

Completed

Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer Patients

NCT00253383

Conditions: Adenocarcinoma, Adnexal Diseases, Anus Diseases, +75 more
Locations: Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States

Veterans Affairs Medical Center - White River Junction White River Junction, Vermont, United States

View Trial Details

Completed

Radiation Therapy as Palliative Treatment of GIST

NCT00515931

Conditions: Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +7 more
Locations: Helsinki University Central Hospital Helsinki, Finland

View Trial Details

Completed

A Clinical Trial to Compare the Pharmacokinetics of Imatinib Mesylate Tablet 400mg (1 Tablet) and Glivec Film-coated Tablet 100mg (4 Tablets)(Phase I)

NCT01751919

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +19 more
Locations: Kyungpook National University Daegu, South Korea

View Trial Details

Gastrointestinal Stromal Tumors

Gastrointestinal Stromal Tumors trial results

Related conditions